학술논문

Characterization of the degradents formed during formulation of rigosertib, a phase III clinical candidate
Document Type
Journal
Source
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY; APR 2 2017, 253 1p.
Subject
Language
English
ISSN
00657727